12950426

Source:http://linkedlifedata.com/resource/pubmed/id/12950426

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0014245, umls-concept:C0024554, umls-concept:C0027396, umls-concept:C0450199, umls-concept:C0473169, umls-concept:C0681850, umls-concept:C1176415, umls-concept:C1550501, umls-concept:C1696465, umls-concept:C1706203, umls-concept:C2349001, umls-concept:C2603343, umls-concept:C2697811
pubmed:issue	5
pubmed:dateCreated	2003-9-2
pubmed:abstractText	Lumiracoxib (Prexige) is a cyclooxygenase-2 (COX-2) selective inhibitor.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8707234
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2 Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Diclofenac, http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Naproxen, http://linkedlifedata.com/resource/pubmed/chemical/Organic Chemicals, http://linkedlifedata.com/resource/pubmed/chemical/PTGS2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandin-Endoperoxide Synthases, http://linkedlifedata.com/resource/pubmed/chemical/Thromboxanes, http://linkedlifedata.com/resource/pubmed/chemical/lumiracoxib
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0269-2813
pubmed:author	pubmed-author:BransonJJ, pubmed-author:FordMM, pubmed-author:KellettNN, pubmed-author:MainWW, pubmed-author:MilosavljevSS, pubmed-author:RordorfCC, pubmed-author:ScottGG
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	18
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	533-41
pubmed:dateRevised	2009-11-6
pubmed:meshHeading	pubmed-meshheading:12950426-Adolescent, pubmed-meshheading:12950426-Adult, pubmed-meshheading:12950426-Cyclooxygenase 2, pubmed-meshheading:12950426-Cyclooxygenase 2 Inhibitors, pubmed-meshheading:12950426-Cyclooxygenase Inhibitors, pubmed-meshheading:12950426-Diclofenac, pubmed-meshheading:12950426-Double-Blind Method, pubmed-meshheading:12950426-Endoscopy, Gastrointestinal, pubmed-meshheading:12950426-Gastrointestinal Diseases, pubmed-meshheading:12950426-Humans, pubmed-meshheading:12950426-Intestinal Mucosa, pubmed-meshheading:12950426-Isoenzymes, pubmed-meshheading:12950426-Male, pubmed-meshheading:12950426-Membrane Proteins, pubmed-meshheading:12950426-Middle Aged, pubmed-meshheading:12950426-Naproxen, pubmed-meshheading:12950426-Organic Chemicals, pubmed-meshheading:12950426-Pilot Projects, pubmed-meshheading:12950426-Prostaglandin-Endoperoxide Synthases, pubmed-meshheading:12950426-Thromboxanes
pubmed:year	2003
pubmed:articleTitle	Gastroduodenal tolerability of lumiracoxib vs placebo and naproxen: a pilot endoscopic study in healthy male subjects.
pubmed:affiliation	Novartis Pharma AG, Basel, Switzerland. christiane.rordorf@pharma.novartis.com
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial